Pacira BioSciences (PCRX) Stock Analysis & AI Equity Report
Pacira BioSciences (PCRX) overview
Pacira BioSciences (PCRX) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 726m and operating profit of USD 19.2m; the year-end share price was 25.88 USD and market capitalisation was USD 1,064m. Pacira BioSciences is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Pacira BioSciences's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
About Pacira BioSciences
Pacira BioSciences develops and markets non-opioid pain treatments. Its commercial products include EXPAREL, a long-acting local analgesic approved for postsurgical pain management; ZILRETTA, an extended-release injection indicated for osteoarthritis knee pain; and iovera, a handheld device that uses controlled cold to provide targeted, drug-free pain control. The company also develops gene therapy candidates for osteoarthritis.
Generate the Pacira BioSciences report
Pacira BioSciences is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Pacira BioSciences and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.
Analyst reports on Pacira BioSciences
Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.